Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Nurr1 Blocking Peptide (AC1333)
Cat.#: ACPP-1333
Specifications
Despition Nurr1 Blocking Peptide for Immunocompetition, Immunodepletion SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1038 Recombinant Human VCAM1 Protein (6×His Tag) (AC1038) 50 µg inquiry ACPP-1124 Recombinant Human MAP2C Protein (AC1124) 25 µl inquiry ACPP-1621 Human LZIC Protein (AC1621) 5 µg inquiry ACPP-1712 Human NME2 Protein (AC1712) 5 µg inquiry ACPP-1337 Neurochondrin Blocking Peptide (AC1337) 250 µg inquiry ACPP-1462 Human CD34 Protein (AC1462) 5 µg inquiry ACPP-1314 Syndecan-1 Blocking Peptide (AC1314) 250 µg inquiry ACPP-1674 Human KCNIP3 Protein (AC1674) 5 µg inquiry ACPP-1808 Human LIF Protein, Yeast (AC1808) 5 µg inquiry ACPP-1324 Insulin Receptor Blocking Peptide (AC1324) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket